GABAA positive allosteric modulator compound, preparation method and application thereof

Described herein are polymorphic forms comprising 2 ', 6-difluoro-5'-[3-(1-hydroxy-1-methylethyl)-imidazo [1, 2-b] [1, 2, 4] triazin-7-yl] biphenyl-2-formonitrile (TPA023B) or a salt thereof. In one aspect, disclosed herein is a crystalline polymorphic salt or co-crystal of TPA023B with ph...

Full description

Saved in:
Bibliographic Details
Main Authors LI ZHENG, NING YUXI, HUBBS JED, HE YUNLIANG, LIU XIANGLEI, TOTZKE, MATTHEW
Format Patent
LanguageChinese
English
Published 30.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Described herein are polymorphic forms comprising 2 ', 6-difluoro-5'-[3-(1-hydroxy-1-methylethyl)-imidazo [1, 2-b] [1, 2, 4] triazin-7-yl] biphenyl-2-formonitrile (TPA023B) or a salt thereof. In one aspect, disclosed herein is a crystalline polymorphic salt or co-crystal of TPA023B with phosphoric acid. In another aspect, disclosed herein is a crystalline polymorphic salt or co-crystal of TPA023B with sulfuric acid. Methods of making and methods of using the same are also described herein. 本文描述了包含2',6-二氟-5'-[3-(1-羟基-1-甲基乙基)-咪唑并[1,2-b][1,2,4]三嗪-7-基]联苯基-2-甲腈(TPA023B)或其盐的多晶型物。在一个方面中,本文公开了TPA023B与磷酸的结晶多晶型盐或共晶。在另一个方面中,本文公开了TPA023B与硫酸的结晶多晶型盐或共晶。本文还描述了其制备方法和使用方法。
Bibliography:Application Number: CN202080074393